0001579600-16-000002.txt : 20160314 0001579600-16-000002.hdr.sgml : 20160314 20160314104456 ACCESSION NUMBER: 0001579600-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160314 DATE AS OF CHANGE: 20160314 EFFECTIVENESS DATE: 20160314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T3D Therapeutics, Inc. CENTRAL INDEX KEY: 0001579600 IRS NUMBER: 461674269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-235878 FILM NUMBER: 161502804 BUSINESS ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-949-0517 MAIL ADDRESS: STREET 1: 1100 BEARGLADES LANE CITY: RALEIGH STATE: NC ZIP: 27615 D/A 1 primary_doc.xml X0707 D/A LIVE 0001579600 T3D Therapeutics, Inc. 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 919-949-0517 DELAWARE None None Corporation true 2013 John Didsbury 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Promoter Charles Lineberry 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Barry Buzogany 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director John A. Golden 68 T.W. Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b true 0001579600-15-000001 2015-02-26 true true false 100000 ROI Capital Partners, LLC None n/a None PO Box 82566 Seattle WA WASHINGTON 98145 All States false 3750200 1210206 2539994 false 18 152399 true 15000 true Represents estimated maximum potential payments, all of which are subject to future contingencies not yet met. 210000 true false T3D Therapeutics, Inc. John Didsbury John Didsbury President and Chief Executive Officer 2016-03-11